Global Next Generation Diabetes Therapy and Drug Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Next Generation Diabetes Therapy and Drug Delivery estimated at US$ 2234.9 million in the year 2022, is projected to reach a revised size of US$ 7852.9 million by 2028, growing at a CAGR of 23.3% during the forecast period 2022-2028.

The market growth is attributed to the rise in the number of diabetic patients globally and the increase in disposable income among these patients. The benefits of using these advanced devices over conventional products, such as painless mode of insulin delivery and improvement in adherence to medication, and rise in the healthcare expenditure are expected to increase the demand for these products, thus fueling the market growth. However, lack of awareness, cost restrains in the developing regions, and less variability in products are expected to hamper the growth.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Next Generation Diabetes Therapy and Drug Delivery companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Next Generation Diabetes Therapy and Drug Delivery market. Further, it explains the major drivers and regional dynamics of the global Next Generation Diabetes Therapy and Drug Delivery market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Johnson & Johnson

Abbott Laboratories

Medtronic

Sanofi

Novo Nordisk

MannKind Corporation

Enteris BioPharma

Dexcom

Senseonics

Medtech

Synertech

Zosano Pharma

Relmada Therapeutics

Eli Lilly and Company

Transdermal Specialties

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Inhalable Insulin

Oral Insulin

Insulin Patches

CGM Systems

Artificial Pancreas

Diagnostic/Clinics

ICUs

Home Healthcare

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Next Generation Diabetes Therapy and Drug Delivery market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Next Generation Diabetes Therapy and Drug Delivery market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Next Generation Diabetes Therapy and Drug Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Next Generation Diabetes Therapy and Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Next Generation Diabetes Therapy and Drug Delivery revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Next Generation Diabetes Therapy and Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Next Generation Diabetes Therapy and Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Johnson & Johnson, Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind Corporation, Enteris BioPharma, Dexcom and Senseonics, etc.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Inhalable Insulin

1.2.3 Oral Insulin

1.2.4 Insulin Patches

1.2.5 CGM Systems

1.2.6 Artificial Pancreas

1.3 Market by Application

1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Diagnostic/Clinics

1.3.3 ICUs

1.3.4 Home Healthcare

1.4 Study Objectives

1.5 Years Considered

2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)

2.2 Next Generation Diabetes Therapy and Drug Delivery Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2017-2022)

2.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Region (2023-2028)

2.5 Global Top Next Generation Diabetes Therapy and Drug Delivery Countries Ranking by Market Size

3.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players

3.1.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2017-2022)

3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players (2017-2022)

3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue

3.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio

3.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2021

3.5 Global Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served

3.6 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service

3.7 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Revenue by Type (2017-2022)

4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Revenue by Type (2023-2028)

5.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Application (2017-2022)

5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2023-2028)

6.1 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022)

6.2 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2028)

6.3 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2028)

6.4 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022)

7.2 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2028)

7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2028)

7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8.1 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022)

8.2 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2028)

8.3 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2028)

8.4 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

8.4.10 Philippines

8.4.11 Vietnam

9.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022)

9.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2028)

9.3 Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2028)

9.4 Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10.1 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022)

10.2 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2028)

10.3 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2028)

10.4 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 UAE

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Details

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.1.4 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.1.5 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

11.1.6 Johnson & Johnson Recent Developments

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.2.4 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.2.5 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

11.2.6 Abbott Laboratories Recent Developments

11.3 Medtronic

11.3.1 Medtronic Company Details

11.3.2 Medtronic Business Overview

11.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.3.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.3.5 Medtronic Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

11.3.6 Medtronic Recent Developments

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.4.4 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.4.5 Sanofi Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

11.4.6 Sanofi Recent Developments

11.5 Novo Nordisk

11.5.1 Novo Nordisk Company Details

11.5.2 Novo Nordisk Business Overview

11.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.5.4 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.5.5 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

11.5.6 Novo Nordisk Recent Developments

11.6 MannKind Corporation

11.6.1 MannKind Corporation Company Details

11.6.2 MannKind Corporation Business Overview

11.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.6.4 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.6.5 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

11.6.6 MannKind Corporation Recent Developments

11.7 Enteris BioPharma

11.7.1 Enteris BioPharma Company Details

11.7.2 Enteris BioPharma Business Overview

11.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.7.4 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.7.5 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

11.7.6 Enteris BioPharma Recent Developments

11.8 Dexcom

11.8.1 Dexcom Company Details

11.8.2 Dexcom Business Overview

11.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.8.4 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.8.5 Dexcom Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

11.8.6 Dexcom Recent Developments

11.9 Senseonics

11.9.1 Senseonics Company Details

11.9.2 Senseonics Business Overview

11.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.9.4 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.9.5 Senseonics Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

11.9.6 Senseonics Recent Developments

11.10 Medtech

11.10.1 Medtech Company Details

11.10.2 Medtech Business Overview

11.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.10.4 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.10.5 Medtech Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

11.10.6 Medtech Recent Developments

11.11 Synertech

11.11.1 Synertech Company Details

11.11.2 Synertech Business Overview

11.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.11.4 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.11.5 Synertech Recent Developments

11.12 Zosano Pharma

11.12.1 Zosano Pharma Company Details

11.12.2 Zosano Pharma Business Overview

11.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.12.4 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.12.5 Zosano Pharma Recent Developments

11.13 Relmada Therapeutics

11.13.1 Relmada Therapeutics Company Details

11.13.2 Relmada Therapeutics Business Overview

11.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.13.4 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.13.5 Relmada Therapeutics Recent Developments

11.14 Eli Lilly and Company

11.14.1 Eli Lilly and Company Company Details

11.14.2 Eli Lilly and Company Business Overview

11.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.14.4 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.14.5 Eli Lilly and Company Recent Developments

11.15 Transdermal Specialties

11.15.1 Transdermal Specialties Company Details

11.15.2 Transdermal Specialties Business Overview

11.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Products and Services

11.15.4 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

11.15.5 Transdermal Specialties Recent Developments

12.1 Next Generation Diabetes Therapy and Drug Delivery Market Trends

12.2 Next Generation Diabetes Therapy and Drug Delivery Market Drivers

12.3 Next Generation Diabetes Therapy and Drug Delivery Market Challenges

12.4 Next Generation Diabetes Therapy and Drug Delivery Market Restraints

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

List of Tables

    Table 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Inhalable Insulin

    Table 3. Key Players of Oral Insulin

    Table 4. Key Players of Insulin Patches

    Table 5. Key Players of CGM Systems

    Table 6. Key Players of Artificial Pancreas

    Table 7. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

    Table 9. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2017-2022) & (US$ Million)

    Table 10. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2017-2022)

    Table 11. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2017-2022) & (US$ Million)

    Table 12. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players (2017-2022)

    Table 13. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2021)

    Table 14. Ranking of Global Top Next Generation Diabetes Therapy and Drug Delivery Companies by Revenue (US$ Million) in 2021

    Table 15. Global 5 Largest Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue (CR5 and HHI) & (2017-2022)

    Table 16. Key Players Headquarters and Area Served

    Table 17. Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service

    Table 18. Date of Key Manufacturers Enter into Next Generation Diabetes Therapy and Drug Delivery Market

    Table 19. Mergers & Acquisitions, Expansion Plans

    Table 20. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022) & (US$ Million)

    Table 21. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2022)

    Table 22. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 23. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2023-2028)

    Table 24. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022) & (US$ Million)

    Table 25. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2022)

    Table 26. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 27. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2023-2028)

    Table 28. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022) & (US$ Million)

    Table 29. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2022) & (US$ Million)

    Table 30. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2023-2028) & (US$ Million)

    Table 31. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2022) & (US$ Million)

    Table 32. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2023-2028) & (US$ Million)

    Table 33. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2022) & (US$ Million)

    Table 34. North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2023-2028) & (US$ Million)

    Table 35. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022) & (US$ Million)

    Table 36. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2022) & (US$ Million)

    Table 37. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2023-2028) & (US$ Million)

    Table 38. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2022) & (US$ Million)

    Table 39. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2023-2028) & (US$ Million)

    Table 40. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2022) & (US$ Million)

    Table 41. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2023-2028) & (US$ Million)

    Table 42. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022) & (US$ Million)

    Table 43. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2022) & (US$ Million)

    Table 44. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2023-2028) & (US$ Million)

    Table 45. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2022) & (US$ Million)

    Table 46. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2023-2028) & (US$ Million)

    Table 47. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2017-2022) & (US$ Million)

    Table 48. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Region (2023-2028) & (US$ Million)

    Table 49. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022) & (US$ Million)

    Table 50. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2022) & (US$ Million)

    Table 51. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2023-2028) & (US$ Million)

    Table 52. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2022) & (US$ Million)

    Table 53. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2023-2028) & (US$ Million)

    Table 54. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2022) & (US$ Million)

    Table 55. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2023-2028) & (US$ Million)

    Table 56. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2020-2022) & (US$ Million)

    Table 57. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2017-2022) & (US$ Million)

    Table 58. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Type (2023-2028) & (US$ Million)

    Table 59. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2017-2022) & (US$ Million)

    Table 60. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Application (2023-2028) & (US$ Million)

    Table 61. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2017-2022) & (US$ Million)

    Table 62. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Country (2023-2028) & (US$ Million)

    Table 63. Johnson & Johnson Company Details

    Table 64. Johnson & Johnson Business Overview

    Table 65. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 66. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 67. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

    Table 68. Johnson & Johnson Recent Developments

    Table 69. Abbott Laboratories Company Details

    Table 70. Abbott Laboratories Business Overview

    Table 71. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 72. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 73. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

    Table 74. Abbott Laboratories Recent Developments

    Table 75. Medtronic Company Details

    Table 76. Medtronic Business Overview

    Table 77. Medtronic Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 78. Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 79. Medtronic Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

    Table 80. Medtronic Recent Developments

    Table 81. Sanofi Company Details

    Table 82. Sanofi Business Overview

    Table 83. Sanofi Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 84. Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 85. Sanofi Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

    Table 86. Sanofi Recent Developments

    Table 87. Novo Nordisk Company Details

    Table 88. Novo Nordisk Business Overview

    Table 89. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 90. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 91. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

    Table 92. Novo Nordisk Recent Developments

    Table 93. MannKind Corporation Company Details

    Table 94. MannKind Corporation Business Overview

    Table 95. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 96. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 97. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

    Table 98. MannKind Corporation Recent Developments

    Table 99. Enteris BioPharma Company Details

    Table 100. Enteris BioPharma Business Overview

    Table 101. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 102. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 103. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

    Table 104. Enteris BioPharma Recent Developments

    Table 105. Dexcom Company Details

    Table 106. Dexcom Business Overview

    Table 107. Dexcom Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 108. Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 109. Dexcom Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

    Table 110. Dexcom Recent Developments

    Table 111. Senseonics Company Details

    Table 112. Senseonics Business Overview

    Table 113. Senseonics Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 114. Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 115. Senseonics Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

    Table 116. Senseonics Recent Developments

    Table 117. Medtech Company Details

    Table 118. Medtech Business Overview

    Table 119. Medtech Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 120. Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 121. Medtech Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis

    Table 122. Medtech Recent Developments

    Table 123. Synertech Company Details

    Table 124. Synertech Business Overview

    Table 125. Synertech Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 126. Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 127. Synertech Recent Developments

    Table 128. Zosano Pharma Company Details

    Table 129. Zosano Pharma Business Overview

    Table 130. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 131. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 132. Zosano Pharma Recent Developments

    Table 133. Relmada Therapeutics Company Details

    Table 134. Relmada Therapeutics Business Overview

    Table 135. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 136. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 137. Relmada Therapeutics Recent Developments

    Table 138. Eli Lilly and Company Company Details

    Table 139. Eli Lilly and Company Business Overview

    Table 140. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 141. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 142. Eli Lilly and Company Recent Developments

    Table 143. Transdermal Specialties Company Details

    Table 144. Transdermal Specialties Business Overview

    Table 145. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product and Services

    Table 146. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)

    Table 147. Transdermal Specialties Recent Developments

    Table 148. Next Generation Diabetes Therapy and Drug Delivery Market Trends

    Table 149. Next Generation Diabetes Therapy and Drug Delivery Market Drivers

    Table 150. Next Generation Diabetes Therapy and Drug Delivery Market Challenges

    Table 151. Next Generation Diabetes Therapy and Drug Delivery Market Restraints

    Table 152. Research Programs/Design for This Report

    Table 153. Key Data Information from Secondary Sources

    Table 154. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Type: 2021 VS 2028

    Figure 2. Inhalable Insulin Features

    Figure 3. Oral Insulin Features

    Figure 4. Insulin Patches Features

    Figure 5. CGM Systems Features

    Figure 6. Artificial Pancreas Features

    Figure 7. Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Application: 2021 VS 2028

    Figure 8. Diagnostic/Clinics Case Studies

    Figure 9. ICUs Case Studies

    Figure 10. Home Healthcare Case Studies

    Figure 11. Next Generation Diabetes Therapy and Drug Delivery Report Years Considered

    Figure 12. Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 13. Global Next Generation Diabetes Therapy and Drug Delivery Market Size 2017-2028 (US$ Million)

    Figure 14. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Region: 2021 VS 2028

    Figure 15. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Region in 2017 VS 2022

    Figure 16. Global Top 10 Next Generation Diabetes Therapy and Drug Delivery Countries Ranking by Market Size (US$ Million) in 2021

    Figure 17. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players in 2021

    Figure 18. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2021)

    Figure 19. The Top 10 and 5 Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2021

    Figure 20. North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company in 2021

    Figure 21. North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2028)

    Figure 22. North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2028)

    Figure 23. North America Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Country (2017-2028)

    Figure 24. U.S. Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 25. Canada Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 26. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company in 2021

    Figure 27. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2028)

    Figure 28. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2028)

    Figure 29. Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Country (2017-2028)

    Figure 30. Germany Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 31. France Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 32. U.K. Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 33. Italy Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 34. Russia Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 35. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company in 2021

    Figure 36. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2028)

    Figure 37. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2028)

    Figure 38. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Region (2017-2028)

    Figure 39. China Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 40. Japan Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 41. South Korea Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 42. India Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 43. Australia Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 44. Taiwan Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 45. Indonesia Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 46. Thailand Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 47. Malaysia Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 48. Philippines Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 49. Vietnam Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 50. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company in 2021

    Figure 51. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2028)

    Figure 52. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2028)

    Figure 53. Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Country (2017-2028)

    Figure 54. Mexico Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 55. Brazil Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 56. Argentina Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 57. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company in 2021

    Figure 58. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2028)

    Figure 59. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2017-2028)

    Figure 60. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Country (2017-2028)

    Figure 61. Turkey Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 62. Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 63. UAE Next Generation Diabetes Therapy and Drug Delivery Revenue (2017-2028) & (US$ Million)

    Figure 64. Johnson & Johnson Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 65. Abbott Laboratories Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 66. Medtronic Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 67. Sanofi Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 68. Novo Nordisk Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 69. MannKind Corporation Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 70. Enteris BioPharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 71. Dexcom Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 72. Senseonics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 73. Medtech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 74. Synertech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 75. Zosano Pharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 76. Relmada Therapeutics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 77. Eli Lilly and Company Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 78. Transdermal Specialties Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)

    Figure 79. Bottom-up and Top-down Approaches for This Report

    Figure 80. Data Triangulation

    Figure 81. Key Executives Interviewed